H.R.1476/S.694, PLASMA Act
2025 · 4th Quarter (Oct 1 - Dec 31)
CSL BEHRING LLC
Filed by SPLITOAK STRATEGIES LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- SPLITOAK STRATEGIES LLC
- Client
- CSL BEHRING LLC
- Filing UUID
- ad3bf17c-04ac-48e2-8764-22d34c8ef7cd
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to plasma-derived therapies in rare diseases and critical care settings
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.